Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient Cancers
Mariko Sasaki(National Cancer Research Institute), Hideaki Ogiwara(National Cancer Research Institute)
Cited by 1
Related Papers
CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes
|PLoS ONE|2012|62
Essential Factors for Incompatible DNA End Joining at Chromosomal DNA Double Strand Breaks In Vivo
|PLoS ONE|2011|18